Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Poli

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
AIDS (London, England)|September 15, 2011
Old and new plasma biomarkers in HIV-1-infected African-American womenGuido Poli
AIDS (London, England)|April 13, 2004
T lymphocytes of HIV-positive individuals: preloaded guns in spite of highly active antiretroviral therapy?Guido Poli
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral LatencyGuido Poli
AIDS (London, England)|October 26, 2013
Cell-to-cell vs. cell-free HIV-1 transmission from macrophages to CD4+ T lymphocytes: lessons from the virology textbookGuido Poli
Immunologic Research|August 27, 2005
Dendritic cells and natural killer cells in the pathogenesis of HIV infectionClaudio Fortis, Guido Poli
Cytokine & Growth Factor Reviews|April 14, 2018
The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infectionElisa Vicenzi, Guido Poli
Molecular Immunology|October 19, 2004
Role of cytokines and chemokines in the regulation of innate immunity and HIV infectionMassimo Alfano, Guido Poli
AIDS (London, England)|October 14, 2017
Chronically infected T-cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1Elisa Vicenzi, Guido Poli
Current Protocols in Immunology|April 25, 2008
Infection of CD4+ primary T cells and cell lines, generation of chronically infected cell lines, and induction of HIV expressionElisa Vicenzi, Guido Poli
Frontiers in Medicine|April 18, 2024
Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimensSalvatore Martini, Guido Poli
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
AIDS (London, England)|September 15, 2011
Old and new plasma biomarkers in HIV-1-infected African-American womenGuido Poli
AIDS (London, England)|April 13, 2004
T lymphocytes of HIV-positive individuals: preloaded guns in spite of highly active antiretroviral therapy?Guido Poli
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral LatencyGuido Poli
AIDS (London, England)|October 26, 2013
Cell-to-cell vs. cell-free HIV-1 transmission from macrophages to CD4+ T lymphocytes: lessons from the virology textbookGuido Poli
Immunologic Research|August 27, 2005
Dendritic cells and natural killer cells in the pathogenesis of HIV infectionClaudio Fortis, Guido Poli
Cytokine & Growth Factor Reviews|April 14, 2018
The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infectionElisa Vicenzi, Guido Poli
Molecular Immunology|October 19, 2004
Role of cytokines and chemokines in the regulation of innate immunity and HIV infectionMassimo Alfano, Guido Poli
AIDS (London, England)|October 14, 2017
Chronically infected T-cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1Elisa Vicenzi, Guido Poli
Current Protocols in Immunology|April 25, 2008
Infection of CD4+ primary T cells and cell lines, generation of chronically infected cell lines, and induction of HIV expressionElisa Vicenzi, Guido Poli
Frontiers in Medicine|April 18, 2024
Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimensSalvatore Martini, Guido Poli
Pageof 13